tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Morten Herholdt, 9 are a BUY (60%), 3 are a HOLD (20%), 3 are a SELL (20%).
Analyst Morten Herholdt, currently employed at HSBC, carries an average stock price target met ratio of 56.94% that have a potential upside of 15.03% achieved within 190 days.
Morten Herholdt’s has documented 30 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GILD, Gilead Sciences at 10-Sep-2026.
Analyst best performing recommendations are on BLUE (BLUEBIRD BIO).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO) at 12/11/2023. The price target of $46.2 was fulfilled within 9 days with a profit of $15.2 (24.76%) receiving and performance score of 27.51.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Apr-2026
$244
$-6.69 (-2.67%)
$215
Buy Since 20-Oct-2021
$250
$-0.69 (-0.28%)
$225
Buy Since 20-Oct-2026
$310
$59.31 (23.66%)
$250
Hold Since 30-Sep-2022
$300
$49.31 (19.67%)
$185
13 days ago
(12-Oct-2026)
7/8 (87.5%)
$74.29 (32.91%)
329
Buy Since 17-May-2026
$270
$19.31 (7.70%)
$240
16 days ago
(09-Oct-2026)
15/41 (36.59%)
$44.29 (19.62%)
175
Which stock is Morten Herholdt most bullish on?
Which stock is Morten Herholdt most reserved on?
What Year was the first public recommendation made by Morten Herholdt?
